TUESDAY, SEPTEMBER 10, 2019
Join us at the Rosewood Hotel for our ninth annual MedtechVision conference. Established in 2011, MedtechVision is an annual conference that brings together business leaders, inventors, investors, physicians and policymakers to discuss real-world solutions to the most challenging issues facing the Medtech industry today.
Precision health holds the rising promise for improved prevention, detection and treatment of disease. Join 200+ Medtech leaders as we discuss how, with continued advances in technology, the practice of a one-size-fits-all imprecise approach to treatment is fading—and in its place, precision healthcare is quickly taking shape.
Tuesday, September 10, 2019
7:30AM – 7:00PM
2825 Sand Hill Rd
Menlo Park, CA 94025
General registration for MedtechVision 2019 is sold out.
Please email firstname.lastname@example.org
to be added to the waiting list.
Join our mailing list to receive information about future events.
Join Mailing List
Registration and Breakfast
The Current Landscape of Precision Health
What is the current state of the precision health landscape? Hear from a key opinion leader within this evolving space as she shares a brief history of the achievements, failures and continued promise of precision health.
Bray Patrick-Lake, Director, Strategic Partnerships, Evidation Health
Driving Improved Outcomes: Diagnostics, Data and Informatics
In recent years, the expanded availability of consumer wearables, sensors, and digital health platforms have flooded healthcare with vast amounts of patient data. Our panel of experts will explore how some companies are effectively gathering enormous volumes of input and tackling the difficult task of contextualizing and extracting salient information to develop more precise solutions that are safe and potentially more effective for patients.
Rowan Chapman, Independent Board Member and Advisor
Amy Friel, VP Marketing, Tidepool
Deb Kilpatrick, CEO, Evidation Health
Community Data Organizer
Co-Founder, The Light Collective
Lunch and Networking
Ferolyn Powell Award
Innovation Beyond R&D: Novel Approaches to Commercialization
From the FDA to MedTech and Pharma, collaboration amongst government and industry is driving new approaches, awareness and adoption of precision medicine. We will highlight some of the recent successes and discuss continued challenges, from new regulatory approaches to market access and commercialization.
Sang’ona Oriedo, Sr. Director of Marketing Communications, iRhythm Technologies
Olivia Ware, Sr. Vice President, Proteus Digital Health
Rebecca Messing Haigler, Value, Market Access & Health Economics Lead, Verily
Brittany Wright Schuck, PhD, Scientific Reviewer, FDA
Speaker: Giulia C. Kennedy, PhD, Chief Scientific and Medical Officer, Veracyte, Inc.
Nada Hanafi, Chief Strategy Officer, Experien Group, LLC
Personalized Data in the Real World
With an increased ability to focus on the attributes of individual patients, targeted therapies are more likely to be efficacious, less likely to lead to adverse side effects, and, in many circumstances, more cost-effective for both patients and payers. We will explore two precision medicine case studies to reveal lessons learned while launching these data-rich solutions, and share inventive approaches that other organizations may elect to utilize in adapting, growing, and providing enhanced value to patients by incorporating elements of precision medicine.
Chi Nguyen, Vice President, Marketing, NeuroPace
Martha Morrell, M.D., Chief Medical Officer, NeuroPace
Andreana Dereniak, Global Strategic Marketing, Head of Business Development & Strategic Alliances, Abbott Diabetes Care
Lynne Lyons, Senior Scientific Affairs Manager, Abbott Diabetes Care
Liz Cumby, CEO, Cumby Consulting Medical Education Experts
Cocktail Reception and Networking
*NOTE: This a working agenda and speakers/updates will be added as the information becomes available.
VP of Marketing, Tidepool
Co-Founder, The Light Collective
Business Strategy and Commercialization Lead, New Analyte Ventures, Abbott
Director, Strategic Partnerships, Evidation Health
VP, Marketing, NeuroPace
Chief Scientific and Medical Officer, Veracyte, Inc.
Senior Scientific Affairs Manager, Abbott Diabetes Care
Chief Medical Officer, NeuroPace
Senior Vice President of US Market and Franchise Development, Proteus Digital Health
Value, Access & Health Economics Lead, Verily Life Sciences
Independent Board Member and Advisor
Senior Director, Marketing Communications, iRhythm Technologies
Scientific Reviewer, U.S. Food and Drug Administration
CEO, Evidation Health
President & Founder, Cumby Consulting, Medical Education Training Practice
Chief Strategy Officer, Experien Group, LLC
Then become a sponsor for one of our future events. See our Sponsorship page for more information.
Become a Sponsor